Brief: Heidelberg Pharma Says Co. And Healthcare Royalty Announce Amendment To Existing Royalty Agreement
07/03/2026 01:05
March 6 (Reuters) - Heidelberg Pharma AG HPHA.DE: EQS-ADHOC: HEIDELBERG PHARMA AND HEALTHCARE ROYALTY ANNOUNCE AMENDMENT TO EXISTING ROYALTY AGREEMENT AND THE PARTICIPATION OF SOLEUS CAPITAL HEIDELBERG PHARMA AG - TO RECEIVE $20 MILLION UPFRONT FROM SOLEUS CAPITAL SUBJECT TO CLOSING CONDITIONS HEIDELBERG PHARMA AG - AGREES TO INCREASED CAP ON TOTAL PAYMENTS IN AMENDED ROYALTY AGREEMENT HEIDELBERG PHARMA AG - HIGH SINGLE-DIGIT ROYALTY TAIL DUE AFTER MAXIMUM ROYALTIES SOLD; REMAINING ROYALTIES REVERT TO HEIDELBERG PHARMA Source text: ID:nEQ3t9G92a Further company coverage: HPHA.DE ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Heidelberg Pharma AG
See all newsBrief: Heidelberg Pharma And Huadong Medicine Receive Nmpa Approval For Hdp-101 Trial In China
Germany's Heidelberg Pharma H1 sales revenue surges, driven by milestone payments
Brief: Heidelberg Pharma Says Co. And Healthcare Royalty Announce Amendment To Existing Royalty Agreement
Brief: Redhill Biopharma Secures Allowance Of Key Chinese Patent Application For Proprietary COVID-19 Treatment, RHB-107
Brief: Heidelberg Pharma Amends Royalty Financing With Healthcare Royalty